Status:
COMPLETED
Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas
Lead Sponsor:
Duke University
Conditions:
Head Trauma
Craniocerebral Injuries
Eligibility:
All Genders
Phase:
NA
Brief Summary
The goal of this study is to determine the sensitivity, specificity, and positive and negative predictive values of the a portable near-infrared-based device (portable NIR-based device), the InfraScan...
Detailed Description
When applicable (conscious patient and/or family or legally authorized representative is present) the study will be introduced to the patient and relevant parties prior to the research team approachin...
Eligibility Criteria
Inclusion
- Any patient who presents to MRRH with suspected head trauma, who is able to or who has a legally authorized representative who is able consent in English, Swahili, or Luganda will be considered for this study.
Exclusion
- None
Key Trial Info
Start Date :
October 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 5 2022
Estimated Enrollment :
672 Patients enrolled
Trial Details
Trial ID
NCT04505293
Start Date
October 5 2021
End Date
August 5 2022
Last Update
March 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710
2
Mbarara Regional Referral Hospital
Mbarara, Uganda